Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2002
01/17/2002WO2001016377A3 Diagnostics and therapeutics for osteoporosis
01/17/2002WO2001016293A3 Dna encoding the human serine protease t
01/17/2002WO2001013118A3 Methods and compositions for diagnosis of hepatoma
01/17/2002WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer
01/17/2002WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF
01/17/2002WO2001011356A3 Methods and apparatus for determining coagulation times
01/17/2002WO2001010468A3 Drug-carrier complexes and methods of use thereof
01/17/2002WO2001007471A3 Cell cycle and proliferation proteins
01/17/2002WO2001007087A3 Enzyme catalyzed anti-infective therapeutic agents
01/17/2002WO2000079009A3 Improved primers and methods for the detection and discrimination of nucleic acids
01/17/2002WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides
01/17/2002WO2000078953A3 Human transport proteins
01/17/2002WO2000078952A3 Human rna metabolism proteins (rmep)
01/17/2002WO2000070023A9 Novel fab fragment libraries and methods for their use
01/17/2002WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
01/17/2002WO1999051284A3 Non-covalent bioconjugates useful for diagnosis and therapy
01/17/2002US20020007249 Personal computer breath analyzer for health-related behavior modification and method
01/17/2002US20020007123 Method and system for characterization and mapping of tissue lesions
01/17/2002US20020006903 Genetic engineering
01/17/2002US20020006673 Electronically-indexed solid-phase assay for biomolecules
01/17/2002US20020006671 Luminescence polarization assays
01/17/2002US20020006670 Monitoring antigen activity in sample; mix blood and antigen in reaction container, incubate, remove mix, detect preferential product in sample
01/17/2002US20020006667 Methods for optimal usage and improved valuation of corrosive petroleum feedstocks and fractions (Law521)
01/17/2002US20020006664 Arrayed transfection method and uses related thereto
01/17/2002US20020006633 Assay for anti transglutaminase antibodies detection useful in celicac disease diagnosis
01/17/2002US20020006632 Immobilised membrane adhering to a transistor by a polysiloxane matrix; analyte detection agent; reduced propensity for antibody aggregation; antigen-binding molecule that is immuno-interactive with a beta -bungarotoxin.
01/17/2002US20020006631 Process for discriminating and counting erythroblasts
01/17/2002US20020006630 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
01/17/2002US20020006629 Affinity matrix bearing tumor-associated carbohydrate-or glycopeptide-based antigens and uses thereof
01/17/2002US20020006628 Methods of diagnosing and monitoring endometrial glandular development
01/17/2002US20020006627 Method for diagnosis of Alzheimer's disease
01/17/2002US20020006624 Diagnosing drug abuse; obtain nucleotide sequence sample, incubate with probes, detect restriction fragment length polymorphism
01/17/2002US20020006622 Generating a molecular profile of genomic DNA by hybridization of labeled nucleic acid representing the genomic DNA to immobilized nucleic acid probes, e.g., arrays or biochips.
01/17/2002US20020006621 Non-invasive method for isolation and detection of fetal DNA
01/17/2002US20020006617 Nucleic acid detection methods using universal priming
01/17/2002US20020006616 Drug screening anticarcinogenic agents; provide cells, expose to antiproliferative agent, evaluate antitumor activity
01/17/2002US20020006614 Detecting structural or synthetic information about chemical compounds
01/17/2002US20020006610 Detection of enterovirus in a sample; provide sample, inoculate sample, monitor sample for presence of enterovirus
01/17/2002US20020006608 Whole blood/mitogen assay for the early detection of a subject infected with hepatitis c virus and kit
01/17/2002US20020006607 Soild supports for use in monitoring osteogenesis
01/17/2002US20020006606 MLK inhibitors for the treatment of neurological disorders
01/17/2002US20020006604 Solid support for the detection of preferential compounds in sample
01/17/2002US20020006444 Extract from a plant crude drug, having given amount of soluble silicon compound calculated as silicon per gram of dry weight, and extract that inhibits production of plasma kallikrein; standardization
01/17/2002US20020006408 Vaccines against eimeria mediated disorder
01/17/2002US20020006391 Genetic engineering
01/17/2002US20020006381 Method for finding nucleotide synthesis inhibitors having fewer side effects
01/17/2002US20020006379 Diagnosis of tissue damage, cancer
01/17/2002US20020006362 Miniaturization
01/17/2002US20020006360 Gas and liquid extraction
01/17/2002US20020006355 Hollow microneedle patch
01/17/2002US20020006271 Method and device for recording sub-titles
01/17/2002US20020005953 SPR sensor plate and immune reaction measuring instrument using the same
01/17/2002US20020005580 Techniques and system for analyte detection
01/17/2002US20020005384 Monitoring variations in electrical potentials
01/17/2002US20020005352 Electrode system
01/17/2002US20020004958 Dyeing hair, textiles; catalytic oxidation
01/17/2002DE10122728A1 Identification of waste plastics includes heating and electrifying plastic mixture, and measuring heating and electrostatic properties of the plastics
01/17/2002DE10032859A1 Verfahren zum Erfassen von Viren A method for detecting viruses
01/17/2002DE10032633A1 Verfahren zum Auffinden von Hemmstoffen der Protoporphyrinogen-Oxidase A method for finding inhibitors of protoporphyrinogen oxidase
01/17/2002DE10031549A1 Gas sensor used for detecting hydrogen comprises pn-diode having sequence of p- and n-doped semiconductor layers, and devices for determining electrical resistance of semiconductor
01/17/2002DE10024970C1 Verfahren und Vorrichtung zum Ausrichten und Verschieben eines Prüflings, wie Tabletten, Pillen, Dragees oder Tablets Method and device for aligning and moving a test specimen such as tablets, pills, dragees or Tablets
01/17/2002DE10024490A1 Clamp for dynamic ageing testing of rubbers and elastomers in ozone gas comprises parallel discs, one with a cam for extending test pieces
01/17/2002CA2416219A1 Artificial antibody polypeptides
01/17/2002CA2416215A1 Relative rates of cytochrome p450 metabolism
01/17/2002CA2415967A1 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip)
01/17/2002CA2415940A1 Fourier transform mass spectrometry of complex biological samples
01/17/2002CA2415919A1 Reagents and methods for identification of binding agents
01/17/2002CA2415902A1 Protein design automation for designing protein libraries with altered immunogenicity
01/17/2002CA2415897A1 Real-time sequence determination
01/17/2002CA2415808A1 Transporters and ion channels
01/17/2002CA2415787A1 Method for determining three-dimensional protein structure from primary protein sequence
01/17/2002CA2415639A1 Distinguishing molecular forms
01/17/2002CA2415484A1 Human myeloma cell line
01/17/2002CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors
01/17/2002CA2415253A1 Bio-probes and use thereof
01/17/2002CA2415179A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
01/17/2002CA2415174A1 Methods and kits for the detection of arginine compounds
01/17/2002CA2415127A1 Down syndrome critical region 1-like 1 proteins
01/17/2002CA2415084A1 Olfactory neuron cultures and method of making and using the same
01/17/2002CA2414986A1 Diagnostic method for the identification of foetal dna in a maternal sample
01/17/2002CA2414933A1 Optical food oil quality sensor
01/17/2002CA2414572A1 Method of identifying conformation-sensitive binding peptides and uses thereof
01/17/2002CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002CA2414447A1 Assay method and system for identification of p2y receptor agonists and antagonists
01/17/2002CA2414403A1 Methods for diagnosis and treatment of psychiatric disorders
01/17/2002CA2414387A1 Drug metabolizing enzymes
01/17/2002CA2414219A1 Lipid metabolism molecules
01/17/2002CA2414198A1 Melanin concentrating hormone receptor ligands
01/17/2002CA2413810A1 Aminoacyl trna synthetases
01/17/2002CA2413663A1 Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery
01/17/2002CA2413549A1 Substrates for powder deposition containing conductive domains
01/17/2002CA2351110A1 Helicobacter felis vaccine
01/16/2002EP1173031A1 Method and device for recording sub-titles
01/16/2002EP1172655A1 Method for detecting megsin protein and use thereof
01/16/2002EP1172654A1 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors
01/16/2002EP1172653A1 Inspection chip for sensor measuring instrument
01/16/2002EP1172652A1 Measuring system
01/16/2002EP1172651A1 Measuring system
01/16/2002EP1172650A2 Combined toxic gas sensor and oxygen sensor
01/16/2002EP1172649A1 Measuring device using biosensor and biosensor used for it, and dedicated standard liquid